Elizabeth Ruth Plummer
- Oncology top 5%
- PARP inhibition in cancer therapy 22
- Cancer Immunotherapy and Biomarkers 8
- Cancer Treatment and Pharmacology 6
- Reproductive Medicine top 5%
- Molecular Biology top 10%
- DNA Repair Mechanisms 15
- Cancer therapeutics and mechanisms 9
- Cancer Research top 10%
- Cancer Genomics and Diagnostics 12
- Cancer, Hypoxia, and Metabolism 6
-
- Glioma Diagnosis and Treatment 7
- Co-authors
- Nicola J. CurtinHuw D. ThomasRichard J. EdmondsonAsima MukhopadhyayHilary CalvertYvette DrewZdeněk HostomskýEvan A. Mulligan
- Journals
- Journal of Clinical Oncology (52 papers)JNCI Journal of the National Cancer Institute (1 paper)Cancer Research (1 paper)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Elizabeth Ruth Plummer
66 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 70
- Oncology 961
- Reproductive Medicine 123
- Molecular Biology 836
- Cancer Research 181
- Immunology 137
Countries citing papers authored by Elizabeth Ruth Plummer
This map shows the geographic impact of Elizabeth Ruth Plummer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Ruth Plummer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Ruth Plummer more than expected).
Fields of papers citing papers by Elizabeth Ruth Plummer
This network shows the impact of papers produced by Elizabeth Ruth Plummer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Ruth Plummer. The network helps show where Elizabeth Ruth Plummer may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Elizabeth Ruth Plummer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 2 | |
| 3 | 2023 | 0 | |
| 4 | 2022 | 8 | |
| 5 | 2021 | 1 | |
| 6 | 2021 | 26 | |
| 7 | 2018 | 15 | |
| 8 | 2018 | 7 | |
| 9 | 2016 | 1 | |
| 10 | 2016 | 2 | |
| 11 | 2015 | 1 | |
| 12 | 2014 | 33 | |
| 13 | 2012 | 95 | |
| 14 | 2011 | 54 | |
| 15 | 2010 | 17 | |
| 16 | 2010 | 191 | |
| 17 | 2009 | 61 | |
| 18 | 2009 | 57 | |
| 19 | 2006 | 84 | |
| 20 | 2005 | 83 |
About Elizabeth Ruth Plummer
Elizabeth Ruth Plummer is a scholar working on Oncology, Cancer Research and Genetics, having authored 69 papers that have together received 1.3k indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (22 papers), DNA Repair Mechanisms (15 papers), Cancer Genomics and Diagnostics (12 papers), Cancer therapeutics and mechanisms (9 papers), Cancer Immunotherapy and Biomarkers (8 papers), Glioma Diagnosis and Treatment (7 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Cancer Treatment and Pharmacology (6 papers). The work is most often cited by research in Oncology (961 citations), Reproductive Medicine (123 citations) and Molecular Biology (836 citations). Elizabeth Ruth Plummer has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Nicola J. Curtin, Huw D. Thomas, Richard J. Edmondson, Asima Mukhopadhyay, Hilary Calvert, Yvette Drew, Zdeněk Hostomský, Evan A. Mulligan, Tomasz Zaremba and Michael Cole. Their work appears in journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.